SCHEMBL1601033

SCHEMBL1601033

CC1CC1CNC(=O)c1ccc(N2CCN(C(=O)c3ccccc3C(F)(F)F)CC2)nn1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCD O00767 15/20 0.72
DCTPP1 Q9H773 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1379082 0.89 SCD (0.71) SCDDCTPP1
SCHEMBL1377098 0.88 SCD (0.84) SCDDCTPP1
SCHEMBL1381346 0.87 SCD (0.71) SCDDCTPP1
SCHEMBL1377378 0.86 SCD (0.79) SCDDCTPP1
SCHEMBL2468191 0.85 SCD (0.55) SCDDCTPP1
SCHEMBL1378991 0.84 SCD (1.00) SCDDCTPP1
SCHEMBL937990 0.84 SCD (0.79) SCDDCTPP1
SCHEMBL1380141 0.84 SCD (0.79) SCDDCTPP1
SCHEMBL1381136 0.83 SCD (1.00) SCDDCTPP1
SCHEMBL1376810 0.83 SCD (1.00) SCDDCTPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648874-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2011-10-05 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP disclosed
US-7919484-B2 Combination therapy XENON PHARMACEUTICALS INC. (CA) 2011-04-05 US disclosed